Bektaş, E. Et Al. 2022. Real-world data of tenofovir alafenamide in treatment-naive and experienced patients with Chronic Hepatitis B: more efficacy, less side effects. 39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi , (Antalya, Turkey), 1159-1162.

Bektaş, E., Yılmaz, A., Kıkılı, C. İ., Nurıyev, K., İstemihan, Z., Şenkal, İ. V., ... İmanov, Z.(2022). Real-world data of tenofovir alafenamide in treatment-naive and experienced patients with Chronic Hepatitis B: more efficacy, less side effects . 39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi (pp.1159-1162). Antalya, Turkey

Bektaş, Erdem Et Al. "Real-world data of tenofovir alafenamide in treatment-naive and experienced patients with Chronic Hepatitis B: more efficacy, less side effects," 39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi, Antalya, Turkey, 2022

Bektaş, Erdem Et Al. "Real-world data of tenofovir alafenamide in treatment-naive and experienced patients with Chronic Hepatitis B: more efficacy, less side effects." 39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi , Antalya, Turkey, pp.1159-1162, 2022

Bektaş, E. Et Al. (2022) . "Real-world data of tenofovir alafenamide in treatment-naive and experienced patients with Chronic Hepatitis B: more efficacy, less side effects." 39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi , Antalya, Turkey, pp.1159-1162.

@conferencepaper{conferencepaper, author={Erdem BEKTAŞ Et Al. }, title={Real-world data of tenofovir alafenamide in treatment-naive and experienced patients with Chronic Hepatitis B: more efficacy, less side effects}, congress name={39. Ulusal Gastroenteroloji Haftası ve 10. Gastroenteroloji Cerrahisi Kongresi}, city={Antalya}, country={Turkey}, year={2022}, pages={1159-1162} }